Resistant to Tyrosine Kinase Inhibitor Therapy
Also known as: Resistant to tyrosine kinase inhibitors
Drug | Drug Name | Drug Description |
---|---|---|
DB04868 | Nilotinib | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. |